Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 1, 2014
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort studyMichael Manns, Stanislas Pol, Ira M Jacobson, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis BYun Bin Lee, Eun Uk Jung, Bo Hyun Kim, et al.
Hepatology International|May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virusYoung-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.
The Korean Journal of Internal Medicine|July 10, 2023
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b studyJeong Heo, Yoon Jun Kim, Sung Wook Lee, et al.
Journal of Gastroenterology and Hepatology|October 5, 2012
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter studyBo Hyun Kim, Yoon Jun Kim, Sook-Hyang Jeong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 17, 2015
Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective studyYeon Seok Seo, Moon Young Kim, Seung Up Kim, et al.
Infectious Diseases and Therapy|April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2013
A nationwide seroepidemiology of hepatitis C virus infection in South KoreaDo Young Kim, In Hee Kim, Sook-Hyang Jeong, et al.
Hepatology (Baltimore, Md.)|July 25, 2007
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo, Ju Hyun Kim, Tae-Hun Kim, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo, Ju Hyun Kim, Young-Hwa Chung, et al.
Pageof 8